What is NeueHealth, Inc. (NEUE) stock price today?

NeueHealth, Inc. (NEUE) is currently trading at $6.75, up 0% today.

What is NEUE P/E ratio?

NeueHealth, Inc.'s P/E ratio is -1.22. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is NEUE return on equity (ROE)?

NeueHealth, Inc.'s return on equity (ROE) is 4.90%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is NeueHealth, Inc.'s market cap?

NeueHealth, Inc. has a market capitalization of $60.94M.

NYSE · Medical - Equipment & Services

NeueHealth, Inc. (NEUE) Stock

$6.75 +0.00% NYSE: NEUE Healthcare

Operating within the United States, NeueHealth, Inc. is a healthcare enterprise dedicated to delivering a diverse array of medical solutions to patients, care providers, and insurance entities.

Valuation

Metric	Value
Price	$6.75
Market Cap	$60.94M
P/E Ratio	-1.22
P/B Ratio	-0.13
P/S Ratio	0.14
EPS (TTM)	$-22.65
52-Week High	$7.66
52-Week Low	$3.79
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	4.90%
ROA	-2.93%
ROCE	-10.27%
Gross Margin	27.67%
Operating Margin	3.98%
Net Margin	-5.13%
Debt/Equity	-0.47
Current Ratio	0.70

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$515.0M	$1.5B	$751.0M	$1.2B	$937.0M
Operating Profit	$-170.0M	$-344.0M	$-369.0M	$-577.0M	$-107.0M
Net Profit	$-248.0M	$-1.2B	$-1.5B	$-1.2B	$-135.0M
EPS	$-143.42	$-150.77	$-190.04	$-150.94	$-22.65
Op Margin	-33.1%	-22.7%	-49.1%	-49.7%	-11.5%

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$1.8B	$3.6B	$4.7B	$1.2B	$544.0M
Total Liabilities	$2.3B	$2.3B	$3.7B	$1.5B	$930.0M
Cash	$488.0M	$289.0M	$217.0M	$87.0M	$83.0M
Borrowings	$28.0M	$155.0M	$350.0M	$370.0M	$205.0M

Latest News

CCTV+: Int'l Congress of Basic Science opens in Beijing CNW Group · Aug 9, 2026 Fed Chair Kevin Warsh May Have Driven a Dagger Through Wall Street's Heart With This Candid 12-Word Statement Motley Fool · Aug 9, 2026 Brown Forman (BF.B) Rebounds, Is It Still Above Fair Value? Simply Wall St. · Aug 9, 2026 Geron (GERN) Back In Focus As Fresh Guidance And Earnings Test Its Undervalued Narrative Simply Wall St. · Aug 9, 2026 National Energy Services Reunited (NESR) Lands Kuwait Contracts, Is The Stock Fully Priced? Simply Wall St. · Aug 9, 2026

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$-57.0M	$82.0M	$234.0M	$-2.7B	$-123.0M
Investing Cash Flow	$-696.0M	$-674.0M	$-859.0M	$2.2B	$374.0M
Financing Cash Flow	$0	$-10.0M	$-4.0M	$-16.0M	$-102.0M
Net Cash Flow	$-35.0M	$573.0M	$871.0M	$-1.6B	$-190.0M
Free Cash Flow	$-64.0M	$52.0M	$207.0M	$-2.7B	$-126.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.01
EV / EBITDA	-2.67
FCF Yield	-43.53%
Quick Ratio	0.70
Interest Coverage	1.25
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACHLAchilles Therapeutics plc	$1.48	+0.68%	-0.85	$60.83M	0.00%
AKYAAkoya Biosciences, Inc.	$1.29	-5.15%	-1.15	$64.44M	0.00%
CCLDCareCloud, Inc.	$1.77	-9.23%	28.94	$75.21M	0.00%
HTBXHeat Biologics, Inc.	$2.38	+0.42%	-1.87	$61.07M	0.00%
NAKANakamoto Inc.	$7.96	-7.23%	-0.27	$138.52M	0.00%

About NeueHealth, Inc.

Operating within the United States, NeueHealth, Inc. is a healthcare enterprise dedicated to delivering a diverse array of medical solutions to patients, care providers, and insurance entities. The company is structured into two primary divisions. Its NeueCare segment directly offers medical treatment to individuals enrolled in ACA marketplace, Medicare, and Medicaid plans. This is achieved through a network of both company-owned and partner clinics, which frequently operate under a risk-bearing model and include brands such as Centrum Health, AssociatesMD, and Premier Medical Associates. Beyond direct care, NeueCare also encompasses a comprehensive integrated system, featuring on-site pharmacy, laboratory, and radiology facilities, alongside specialized services focused on population health. Furthermore, it provides essential support for managing chronic conditions, coordinating patient transitions between care settings, and streamlining specialist referrals. The NeueSolutions segment, on the other hand, is designed to empower healthcare professionals and medical practices, assisting them in excelling within value-based care agreements. This division also actively works to enhance access to healthcare for Medicare beneficiaries. Established in 2015, the firm is based in Doral, Florida. It adopted the name NeueHealth, Inc. in January 2024, having previously operated as Bright Health Group, Inc.

NeueHealth, Inc. is headquartered in US.

NeueHealth, Inc. (NEUE) stock trades at $6.75 with a market capitalization of $60.94M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.22, reflecting a net loss over the last twelve months, a negative price-to-book of -0.13, reflecting negative shareholders' equity, price-to-sales of 0.14. Over the past 52 weeks the stock has ranged between $3.79 and $7.66, and currently trades 11.9% below its 52-week high.

On profitability, NeueHealth, Inc. generates a return on equity (ROE) of 4.90% (not meaningful, as shareholders' equity is negative), return on capital employed of -10.27%, an operating margin of 3.98%, a net profit margin of -5.13%.

Official website: www.neuehealth.com